Joint Press Conference: Blumenthal & Valisure Address Benzene in Acne Products

Valisure partnered with Senator Richard Blumenthal to bring critical attention to the alarming presence of benzene, a known carcinogen, in acne treatment products. In a joint press conference held in Hartford, CT, Valisure’s President, David Light, and Senator Blumenthal discussed the findings of Valisure’s research and their implications for consumer safety.

The event, covered by NBC CT, highlighted the urgent need for action, with Senator Blumenthal announcing his formal letter to the FDA, as reported by Bloomberg. The letter strongly advocates for immediate recalls and heightened regulatory oversight to protect consumers, particularly vulnerable youth who frequently use these products.

Valisure remains steadfast in its commitment to advancing public health through rigorous testing, advocacy, and collaboration with policymakers to ensure transparency and safety in consumer products.

Joint Press Conference: Blumenthal & Valisure Address Benzene in Acne Products

October 31, 2024

Valisure partnered with Senator Richard Blumenthal to bring critical attention to the alarming presence of benzene, a known carcinogen, in acne treatment products. In a joint press conference held in Hartford, CT, Valisure’s President, David Light, and Senator Blumenthal discussed the findings of Valisure’s research and their implications for consumer safety.

The event, covered by NBC CT, highlighted the urgent need for action, with Senator Blumenthal announcing his formal letter to the FDA, as reported by Bloomberg. The letter strongly advocates for immediate recalls and heightened regulatory oversight to protect consumers, particularly vulnerable youth who frequently use these products.

Valisure remains steadfast in its commitment to advancing public health through rigorous testing, advocacy, and collaboration with policymakers to ensure transparency and safety in consumer products.

Joint Press Conference: Blumenthal & Valisure Address Benzene in Acne Products

Valisure partnered with Senator Richard Blumenthal to bring critical attention to the alarming presence of benzene, a known carcinogen, in acne treatment products. In a joint press conference held in Hartford, CT, Valisure’s President, David Light, and Senator Blumenthal discussed the findings of Valisure’s research and their implications for consumer safety.

The event, covered by NBC CT, highlighted the urgent need for action, with Senator Blumenthal announcing his formal letter to the FDA, as reported by Bloomberg. The letter strongly advocates for immediate recalls and heightened regulatory oversight to protect consumers, particularly vulnerable youth who frequently use these products.

Valisure remains steadfast in its commitment to advancing public health through rigorous testing, advocacy, and collaboration with policymakers to ensure transparency and safety in consumer products.

Valisure partnered with Senator Richard Blumenthal to bring critical attention to the alarming presence of benzene, a known carcinogen, in acne treatment products. In a joint press conference held in Hartford, CT, Valisure’s President, David Light, and Senator Blumenthal discussed the findings of Valisure’s research and their implications for consumer safety.

The event, covered by NBC CT, highlighted the urgent need for action, with Senator Blumenthal announcing his formal letter to the FDA, as reported by Bloomberg. The letter strongly advocates for immediate recalls and heightened regulatory oversight to protect consumers, particularly vulnerable youth who frequently use these products.

Valisure remains steadfast in its commitment to advancing public health through rigorous testing, advocacy, and collaboration with policymakers to ensure transparency and safety in consumer products.